StudyRareStudyRare
Log in to add personal notes on this page.

An infant with hepatomegaly has severe hypoglycemia not responding to glucagon. Labs show lactic acidosis, hyperuricemia, and hyperlipidemia.

AR; biallelic loss-of-function variants in either part of the glucose-6-phosphatase system of the endoplasmic reticulum.

  • Type 1a: G6PC1 (formerly G6PC; glucose-6-phosphatase catalytic subunit)
  • Type 1b: SLC37A4 (G6P transporter) - also has neutropenia

Glucose-6-phosphatase sits in the membrane of the endoplasmic reticulum in liver and kidney cells and performs the last step of both glycogen breakdown and gluconeogenesis: it turns glucose-6-phosphate into free glucose. The G6P transporter (SLC37A4) carries glucose-6-phosphate from the cytoplasm into the endoplasmic reticulum where the phosphatase works. Losing either protein means the liver cannot release glucose from any source, which is why fasting hypoglycemia is severe and glucagon raises lactate instead of glucose.

Glucose-6-phosphate that cannot leave is pushed into other routes: back into glycogen, which with fat fills the liver and kidneys (hepatomegaly, nephromegaly), through glycolysis to lactate and triglycerides, and through the pentose phosphate pathway to uric acid. The same logic bans fructose, galactose, and sucrose, which are converted to glucose-6-phosphate, and explains cornstarch, a slow-release glucose source.

Neutropenia in type 1b follows the transporter's role outside the liver. Neutrophils need it to clear 1,5-anhydroglucitol-6-phosphate, a glucose-6-phosphate look-alike; without it the compound builds up and impairs neutrophil function and survival. Empagliflozin makes the kidney excrete its precursor and improves neutrophil counts and bowel disease.

Genotype predicts little. Homozygous G6PC1 c.648G>T (most Japanese patients) gives milder hypoglycemia.

phosphoglucomutase 1PGM1transporter into the endoplasmicreticulum, thenglucose-6-phosphataseSLC37A4, G6PC1GSD Iglucose-1-phosphateglucose-6-phosphatefree glucose intoblood (liver)
Excerpt from glycogen synthesis and breakdown. See the full pathway.

Part of glycogen synthesis and breakdown.

Glycogen degradation and gluconeogenesis, final common step in the liver.

glycogen breakdown, gluconeogenesis → glucose-6-phosphate → G6P transporter (SLC37A4; block in 1b) → glucose-6-phosphatase (the block in 1a) → free glucose → blood

  • Accumulates: glucose-6-phosphate, measured through its overflow: glycogen in liver and kidney, high lactate, uric acid, and triglycerides.
  • Missing: free glucose released by the liver, so infants present when feeds space out (age 3 to 4 months) and meals come every 3 to 4 hours.
  • Workbook: 6.C. Hepatic glycogen storage diseases
  • Severe fasting hypoglycemia
  • Hepatomegaly (massive), nephromegaly
  • Lactic acidosis, hyperuricemia, hyperlipidemia
  • "Doll-like" face
  • Hepatic adenomas (long-term)
  • Type 1b: Neutropenia, IBD-like symptoms
  • Not on RUSP; suspected from hepatomegaly with fasting hypoglycemia
  • Characteristic biochemistry: lactic acidosis, hyperuricemia, hyperlipidemia; hypoglycemia fails to respond to glucagon
  • Confirmation: biallelic variants in G6PC1 (type 1a) or SLC37A4 (type 1b); enzyme assay on liver tissue is rarely needed now
  • Frequent feedings, cornstarch, G-CSF (type 1b)

GSD Type 1 = "1iver" only: primarily liver and kidney (2 words in "Von Gierke," so 2 organs). No myopathy (unlike other GSDs). T1 is the #1 most common GSD (~90%).

"FAN-C" building blocks: when Carbs are out (GSD T1), catabolism of the other 3 building blocks goes up: increased Fats/triglycerides, increased uric Acid (from Nucleic acid breakdown), and increased laCtate (accumulated glucose-6-phosphate shunted into glycolysis).

GSD1b has a "bonus": neutropenia. Blood cell counts are low and inflammatory bowel disease occurs in type 1b.

Memory aid:GSD1a song (von Gierke)

Reference Links